Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-05

Clinical Trial Update: Thiazolidinedione (TZD) on the Diabetic Retinopathy and Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of a thiazolidinedione (TZD) on diabetic retinopathy and nephropathy in people with diabetes; sponsor is Taipei V…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thiazolidinedione (TZD) (thiazolidinedione)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Diabetes | Phase 4 | Status: UNKNOWN